Azilva, Abraxane, and More Major Meds Get Add-On PMPs under Ad-Hoc Rule in FY2023: Poll

A special measure to grant a raise in the price maintenance premium (PMP) will be applied to a host of mainstay brands including Azilva (azilsartan) and Abraxane (paclitaxel) in Japan’s FY2023 “off-year” drug price revision this April, according to a...read more